KyrodataKyrodata
PanelNewsPricing

Ready to get started?

Create an account in a minute, or talk to us to design a package that fits your company.

Contact sales

See what you'll pay

Flat subscription pricing, no hidden fees and no lock-in.

View pricing

See the panel working

Imports and exports on real data, with filters and charts, in two minutes.

Open the panel

Get started

  • Dashboard
  • Costs
  • Diagnostics
  • Pricing

Follow the market

  • News
  • Editorial
  • Exports
  • Imports
  • Markets

Let us help you

  • About
  • Support
  • Talk to sales
  • Developers
  • Status
KyrodataKyrodata
  • Terms
  • Privacy
  • Refund
© 2026 Kyrodata. All rights reserved.
Kyrodata · CNPJ 66.455.947/0001-03
Rua Professor Ciridião Buarque, 75 — Vila Anglo Brasileira, São Paulo/SP, CEP 05028-000 · [email protected]
  1. News
  2. Immunological Products

Immunological Products

Coverage of Immunological Products in Brazilian foreign trade.
Editorial illustration on Brazilian foreign trade for the foreign trade chapter
★Featured

Brazil's biologicals to Colombia surge nearly 770% in the period

Brazil shipped 1,544 tonnes of vaccines and immunologicals to Colombia in full-year 2025, against a multi-year average of 178 tonnes, marking a historic.

May 24·2min

More on this topic

Editorial illustration on Brazilian foreign trade for the foreign trade chapter
Immunological Products

China becomes Brazil's top buyer of biologicals

China jumped from 14th to 1st in Brazil's biological products exports in 2025, with FOB reaching US$13.5M and share of 10.5% — a 392% surge over 2024.

May 22·4min
Editorial illustration on Brazil's exports of Sangue humano; sangue animal preparado para usos terapêuticos, profilácticos ou de diagnóstico; anti-soros, outras fracções do sangue, produtos imunológicos modificados, mesmo obtidos por via biotecnológica; vacinas, toxinas, culturas de microrganismos (e with China
Immunological Products

China is set to lead Brazil's immunological exports through 2026

China's rank for Brazilian immunological products vaulted from #14 to #1 in 2025, with its market share expanding from 2.2% to a leading 10.5%.

May 12·3min

Related topics

ExportsChinaColombiaTrade GrowthPharmaceuticals and Biotechnology